Medicare Enrolled

Dr. Michael Ashigbi, M.D.

Hematology & Oncology · Tyler, TX
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
721 CLINIC DR, Tyler, TX 75701
9035926152
Registered in NPPES since 2005
NPI: 1649275355 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Ashigbi from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Ashigbi? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Ashigbi

Dr. Michael Ashigbi is a hematology & oncology specialist in Tyler, TX, with 21 years of NPI registration. Based on federal Medicare data, Dr. Ashigbi performed 1,169 Medicare services in 2023. These records do not provide a deduplicated patient total.

Between the years covered by Open Payments, Dr. Ashigbi received a total of $2,403 from 25 pharmaceutical and/or device companies across 56 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Ashigbi is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 21 years of NPI registration ▲ Top 47% volume in TX $2,403 industry payments

Medicare Practice Summary — 2023

Medicare Utilization ↗
1,169
Medicare services
Top 47% in TX for hematology & oncology
Not available
Unique patients (not deduplicated)
$65
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
620 $66 $232
Hospital follow-up visit, moderate complexity
Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service.
187 $60 $212
Chronic care management, first 20 min/month
This service covers the first 20 minutes of clinical staff time directed by a healthcare professional each calendar month to manage chronic conditions.
92 $39 $95
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
76 $107 $326
Hospital follow-up visit, low complexity
Follow-up hospital visit for an established patient with straightforward or low-level medical decision making. The visit requires at least 25 minutes of time spent on the day of service.
54 $37 $115
New patient office visit, complex (60-74 min) 44 $114 $495
Hospital follow-up visit, high complexity
Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter.
34 $87 $306
Office visit for established patient
An office visit for an existing patient that may not require the healthcare professional to be present.
26 $6 $27
Initial hospital admission, low complexity
Initial hospital inpatient or observation care for a new patient involving straightforward or low-level medical decision making, with at least 40 minutes total time on the date of the encounter.
25 $63 $298
Initial hospital admission, moderate complexity
Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter.
11 $93 $402
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.

Industry Payment Transparency

Open Payments through 2024 ↗
$2,403
Total received (2018-2024)
Avg $343/year across 7 years
Bottom 44% in TX for hematology & oncology
25
Companies
56
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →

Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$523
2023
$483
2022
$35
2021
$90
2020
$349
2019
$482
2018
$440

Payments by company (2024)

ABBVIE INC.
$155
AstraZeneca Pharmaceuticals LP
$125
Janssen Biotech, Inc.
$115
Novartis Pharmaceuticals Corporation
$41
Genentech USA, Inc.
$25
ARRAY BIOPHARMA INC
$22
PFIZER INC.
$21
CSL Behring
$20
Top 3 companies account for 75.3% of 2024 payments
All-time payments by company (2018-2024) ›
Myriad Genetic Laboratories, Inc.
$332
AstraZeneca Pharmaceuticals LP
$245
Celgene Corporation
$208
ABBVIE INC.
$155
Genentech USA, Inc.
$153
Takeda Pharmaceuticals U.S.A., Inc.
$146
Janssen Biotech, Inc.
$140
Puma Biotechnology, Inc.
$125
Amgen Inc.
$122
Pharmacyclics LLC, An AbbVie Company
$117
Daiichi Sankyo Inc.
$113
Merck Sharp & Dohme Corporation
$111
Novartis Pharmaceuticals Corporation
$104
Ipsen Biopharmaceuticals, Inc
$71
Gilead Sciences, Inc.
$51
Exelixis Inc.
$42
Sun Pharmaceutical Industries Inc.
$23
EAGLE PHARMACEUTICALS, INC.
$23
ARRAY BIOPHARMA INC
$22
Dendreon Pharmaceuticals LLC
$22
PFIZER INC.
$21
CSL Behring
$20
GlaxoSmithKline, LLC.
$18
Karyopharm Therapeutics Inc.
$15
Clovis Oncology, Inc.
$4
Top 3 companies account for 32.7% of all-time payments
Associated products mentioned in payments ›
BLENREP · CALQUENCE · Cabometyx · DARZALEX · ELIQUIS · EPKINLY · Enhertu · IMBRUVICA · IMFINZI · IMLYGIC · KEYTRUDA · KISQALI · Kcentra · Kyprolis · LUTATHERA · LYNPARZA · MYRISK · NINLARO · Nerlynx · Odomzo · Onivyde · PROMACTA · PROVENGE · Revlimid · Rubraca · Ryanodex · TECENTRIQ · TECVAYLI · Tecentriq · XALKORI · XPOVIO · Zydelig · myRisk
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Looking for a hematology & oncology specialist in Tyler?
Compare hematology & oncology specialists in the Tyler area by procedure volume, costs, and industry payment transparency.
Browse hematology & oncology specialists nearby

Geographic Context

Hematology & oncology specialists in nearby ZIP areas
10
County median income
$71,923
Nearest hospital to ZIP centroid (approximate)
UT HEALTH EAST TEXAS TYLER REGIONAL HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPES NPPES snapshot; verify current record
Medicare Enrollment PECOS PECOS snapshot
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not included N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Ashigbi is a clinical cardiology specialist, with moderate Medicare volume, with 21 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Ashigbi experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Ashigbi performed 620 office visit, established patient (30-39 min) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Ashigbi receive payments from pharmaceutical companies?
Yes. Dr. Ashigbi received a total of $2,403 from 25 companies across 56 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Ashigbi's costs compare to other hematology & oncology specialists in Tyler?
Dr. Ashigbi's average Medicare payment per service is $65. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Ashigbi) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
About this page

This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Industry payment disclosure alone establishes neither wrongdoing nor legality. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →